The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | B | Blood and blood forming organs | |
| 2 | B02 | Antihemorrhagics | |
| 3 | B02B | Vitamin K and other hemostatics | |
| 4 | B02BD | Blood coagulation factors | |
| 5 | B02BD01 | Coagulation factor IX, II, VII and X in combination |
| Active Ingredient | Description | |
|---|---|---|
| Coagulation factor IX complex |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| KCENTRA Powder for solution for infusion, lyophilized | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.